A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
2022
The Egyptian Journal of Radiology and Nuclear Medicine
Background Imaging of idiopathic inflammatory myopathies (IIMs) is challenging, and no pathognomonic signs exist. Different tracers have been tested for this purpose, mainly inflammation markers including technetium-99m-pyrophosphate (PYP). We aimed to examine the utility of fluorine-18-fluorodeoxyglucose (FDG) relative to PYP in idiopathic inflammatory myopathy (IIM). Methods Using visual grading and CT-guided muscular segmentation and standardized uptake values (SUVs), we assessed muscular
doi:10.1186/s43055-022-00822-z
fatcat:5imp43mgyvf5nmteuxysw74f5q